Table 2. Univariate analysis for association of various clinical factors with different subtypes of salivary gland tumours.
| Tumour type | ACC | SDC | MEC | MASC |
p-value (chi-square method) |
|---|---|---|---|---|---|
| Male sex | 5/11 (45%) | 10/11 (91%) | 7/7 (100%) | 0/1 (0%) | 0.01 |
| Female sex | 6/11 (55%) | 1/11 (9%) | 0/7 (0%) | 1/1 (100%) | 0.02 |
| Upfront advanced disease | 2/11 (18%) | 6/11 (55%) | 5/7 (71%) | 0/1 (0%) | 0.09 |
| Recurrent disease | 9/11 (82%) | 5/11 (45%) | 2/7 (29%) | 1/1 (100%) | 0.06 |
| Lung metastases | 7/11 (64%) | 9/11 (82%) | 0/7 (0%) | 1/1 (100%) | 0.04 |
| AR | 1/9 (11%) | 9/10 (90%) | 1/6 (17%) | 0/1 (0%) | 0.001 |
| HER2 | 0/8 (0%) | 6/11 (55%) | 1/5 (20 %) | 0/1 (0%) | 0.031 |
| Pan TRK | NA | NA | NA | 1/1(100%) | |
| Response rate to first-line therapy | 6/8 (75%) | 4/7 (57%) | 0/6 (0%) | NA | 0.017 |